Hormonal treatment

Hormone replacement therapy (HRT) during menopause: when is it necessary?

Many women enter menopause without sufficient information about the available treatment options. Hormone replacement therapy (HRT) is a combination of estrogens, with or without progestins, that can be prescribed during menopause to compensate for the physiological decline in these hormones. There is much disagreement surrounding its use, and many professionals still advise against it from the outset due to the potential risks attributed to it a couple of decades ago. Our specialist in Gynecology and Obstetrics and Functional Medicine, Elisa Llurba, Professor at the Autonomous University of Barcelona and Medical Director of BeDona, discusses this topic., It reveals the truths and lies about this medical treatment.

What does science say about this treatment?

Current scientific evidence, and most recommendations from scientific societies on the matter, indicate that HRT is an effective and beneficial treatment in patients without contraindications, who are under 60 years of age or who have been menopausal for less than 10 years.

However, there has been much disagreement regarding the necessity of HRT. A 2000 study conducted in the United States reported an increased risk of breast cancer and cardiovascular events in patients taking HRT. Because of this data, HRT went from being a widely used treatment in our mothers' generation to being practically reserved for patients with severe symptoms or very early menopause (before age 40).

This study was heavily criticized at the time because the average age of the women was 62. This indicates that these were not perimenopausal women (45-55 years old), but rather postmenopausal women, for whom treatment may not have been necessary.

What is certain is that this treatment can have some contraindications and risks. Therefore, it is recommended to consult with your gynecologist to assess, on an individual basis and considering other variables, the need for and the most beneficial type of HRT for each woman.

Another important consideration is that not all HRTs are the same. Depending on the type of hormone, whether or not it is combined with progestins, and the route of administration, the results and risks differ.

Risks of HRT, truths and lies

Breast cancer

The relationship between HRT and potential risks is influenced by the duration of treatment, the timing of treatment relative to menopause, the type of hormones, and the route of administration. In this regard, there appears to be a slight increased risk of breast cancer, but only in the group of patients who used combined progestogen therapy, and this increased risk depended on the duration of treatment.

It is important to note that, despite the increased risk of breast cancer, mortality from this cancer was not higher in the group undergoing HRT. How can this be explained? Firstly, because, due to the treatment, women undergo regular checkups, increasing the ability to detect cancer at early stages. Furthermore, these tumors are usually hormone-sensitive, which generally have a better prognosis.

Cognitive health

Dementia is the loss of cognitive ability and is related to age. Women are at higher risk of developing any type of dementia, primarily Alzheimer's and dementia secondary to vascular insufficiency. Estrogen receptors are not only found in the reproductive system and breasts, but in all organs of our body, including the brain. A recent study that reviewed all available evidence on the relationship between hormone replacement therapy (HRT) and dementia prevention showed an 11 to 33% lower risk of dementia in women who received HRT.

Cardiovascular risk

Hormone replacement therapy (HRT) is associated with an increased risk of cardiovascular events, primarily thrombosis and stroke. This association appears to be particularly strong in patients who started treatment after age 60 or more than 10 years after menopause. Recent studies have observed that women taking HRT have a reduced risk of myocardial infarction (as measured by the 21% assay). Furthermore, it seems clear that women using HRT have a better profile in cardiovascular risk factors such as insulin resistance, lipid levels, and glucose levels.

Need to personalize treatment

Many women enter menopause unaware that therapeutic options like HRT exist. That's why at BeDona we offer the necessary support for this stage of your life in various formats:

  • Informative articles
  • Free videos
  • Hormonal balancing and anti-inflammatory program for menopause
  • Online visits with expert gynecologists in this field and in functional medicine to assess each case individually.

Related Articles

Don't miss the first edition of our newsletter Subscribe to stay tuned